Drug Information

Drug General Information
Drug ID
D0K8DH
Former ID
DNC012641
Drug Name
4-Biphenyl-4-yl-2-hexyl-1H-imidazole
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527102]
Formula
C21H24N2
Canonical SMILES
CCCCCCC1=NC=C(N1)C2=CC=C(C=C2)C3=CC=CC=C3
InChI
1S/C21H24N2/c1-2-3-4-8-11-21-22-16-20(23-21)19-14-12-18(13-15-19)17-9-6-5-7-10-17/h5-7,9-10,12-16H,2-4,8,11H2,1H3,(H,22,23)
InChIKey
LLLKBKRUIUYVOU-UHFFFAOYSA-N
PubChem Compound ID
9922499
Target and Pathway
Target(s) Sodium channel Target Info Inhibitor [527102]
Voltage-gated sodium channel subunit alpha Nav1.3 Target Info Inhibitor [527102]
KEGG Pathway Dopaminergic synapse
Reactome Interaction between L1 and AnkyrinsR-HSA-445095:Interaction between L1 and Ankyrins
References
Ref 527102Bioorg Med Chem Lett. 2004 Jul 5;14(13):3521-3.2-Alkyl-4-arylimidazoles: structurally novel sodium channel modulators.
Ref 527102Bioorg Med Chem Lett. 2004 Jul 5;14(13):3521-3.2-Alkyl-4-arylimidazoles: structurally novel sodium channel modulators.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.